Zobrazeno 1 - 6
of 6
pro vyhledávání: '"chronische spontane urtikaria"'
Autor:
Ana Giménez‐Arnau, Marcus Maurer, Jonathan Bernstein, Petra Staubach, Nathalie Barbier, Eva Hua, Thomas Severin, Yolandi Joubert, Reinhold Janocha, Maria‐Magdalena Balp
Publikováno v:
Clinical and Translational Allergy, Vol 12, Iss 2, Pp n/a-n/a (2022)
Abstract Background Chronic spontaneous urticaria (CSU) negatively impacts patients' sleep, thereby reducing health‐related quality of life (HRQoL). Half of patients with inadequately controlled CSU report sleep interference often or every night, w
Externí odkaz:
https://doaj.org/article/c654749ec2044c6fa71aef8c27a9caa8
Autor:
Ivan Cherrez‐Ojeda, Emanuel Vanegas, Annia Cherrez, Miguel Felix, Karsten Weller, Markus Magerl, Rasmus Robin Maurer, Valeria L. Mata, Alicja Kasperska‐Zajac, Agnieszka Sikora, Daria Fomina, Elena Kovalkova, Kiran Godse, Nimmagadda Dheeraj Rao, Maryam Khoshkhui, Sahar Rastgoo, Roberta F. J. Criado, Mohamed Abuzakouk, Deepa Grandon, Martijn B. A. Van Doorn, Solange Oliveira Rodrigues Valle, Eduardo Magalhães De Souza Lima, Simon Francis Thomsen, German D. Ramón, Edgar E. Matos Benavides, Andrea Bauer, Ana M. Giménez‐Arnau, Emek Kocatürk, Carole Guillet, Jose Ignacio Larco, Zuo‐Tao Zhao, Michael Makris, Carla Ritchie, Paraskevi Xepapadaki, Luis Felipe Ensina, Sofia Cherrez, Marcus Maurer
Publikováno v:
Clinical and Translational Allergy, Vol 11, Iss 10, Pp n/a-n/a (2021)
Abstract Background Information/communication technologies such as mobile phone applications (apps) would enable chronic urticaria (CU) patients to self‐evaluate their disease activity and control. Yet, recently Antó et al (2021) reported a global
Externí odkaz:
https://doaj.org/article/76ba83ee17de440ea2e36c1c6e500157
Autor:
Ana Giménez‐Arnau, Marcus Maurer, Jonathan Bernstein, Petra Staubach, Nathalie Barbier, Eva Hua, Thomas Severin, Yolandi Joubert, Reinhold Janocha, Maria‐Magdalena Balp
Publikováno v:
Clinical and translational allergy. 12(2)
Background: Chronic spontaneous urticaria (CSU) negatively impacts patients' sleep, thereby reducing health-related quality of life (HRQoL). Half of patients with inadequately controlled CSU report sleep interference often or every night, which can l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a4bcb90ac0fe8e59ddbb00b7495a14e
https://pubmed.ncbi.nlm.nih.gov/35218324
https://pubmed.ncbi.nlm.nih.gov/35218324
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Giménez-Arnau A; Department of Dermatology, Hospital del Mar, Institut Mar d´Investigacions Mèdiques, Universitat Autònoma, Barcelona, Spain., Maurer M; Department of Dermatology and Allergy, Dermatological Allergology, Allergie-Centrum-Charité, Charité - Universitätsmedizin Berlin, Berlin, Germany., Bernstein J; Bernstein Allergy Group and Bernstein Clinical Research Center, College of Medicine, Cincinnati, Ohio, USA., Staubach P; Department of Dermatology, University Medical Center Mainz, Mainz, Germany., Barbier N; Novartis Pharma AG, Basel, Switzerland., Hua E; China Novartis Institutes for Biomedical Research Co. Ltd, Shanghai, China., Severin T; Novartis Pharma AG, Basel, Switzerland., Joubert Y; Novartis Pharma AG, Basel, Switzerland., Janocha R; Novartis Pharma AG, Basel, Switzerland., Balp MM; Novartis Pharma AG, Basel, Switzerland.
Publikováno v:
Clinical and translational allergy [Clin Transl Allergy] 2022 Feb; Vol. 12 (2), pp. e12121.